Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)

Clinical trial NCT07662863 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07662863
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Metastatic Urothelial Carcinoma Urothelial Carcinoma Peripheral Neuropathy

Start date: 2026-07-15
Primary completion: 2028-12-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.